In summary, HMGB1 exerts diverse functions in the advancement, metastatic potential, and therapeutic recalcitrance of prostate cancer, positioning it as a promising candidate for both targeted therapy and prognostic evaluation. Here, HMGB1 is linked to prostate carcinoma.